| Real-world effectiveness of benralizumab in severe eosinophilic asthma JE Kavanagh, AP Hearn, J Dhariwal, G d’Ancona, A Douiri, C Roxas, ... Chest 159 (2), 496-506, 2021 | 198 | 2021 |
| Real-world effectiveness and the characteristics of a “super-responder” to mepolizumab in severe eosinophilic asthma JE Kavanagh, G d’Ancona, M Elstad, L Green, M Fernandes, L Thomson, ... Chest 158 (2), 491-500, 2020 | 151 | 2020 |
| Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma G d'Ancona, J Kavanagh, C Roxas, L Green, M Fernandes, L Thomson, ... European Respiratory Journal 55 (5), 2020 | 73 | 2020 |
| NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients P Drakatos, L Marples, R Muza, S Higgins, N Gildeh, R Macavei, ... Sleep medicine 53, 181-188, 2019 | 67 | 2019 |
| The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma AP Hearn, J Kavanagh, G d'Ancona, C Roxas, L Green, L Thomson, ... The journal of allergy and clinical immunology. In practice 9 (5), 2093-2096. e1, 2021 | 49 | 2021 |
| Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice P Drakatos, D Lykouras, G D'Ancona, S Higgins, N Gildeh, R Macavei, ... Sleep Medicine 35, 80-84, 2017 | 47 | 2017 |
| Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma. JE Kavanagh, AP Hearn, G d'Ancona, J Dhariwal, C Roxas, L Green, ... Allergy 76 (6), 2021 | 41 | 2021 |
| Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis AM Nanzer, J Dhariwal, J Kavanagh, A Hearn, M Fernandes, L Thomson, ... ERJ open research 6 (4), 2020 | 32 | 2020 |
| Cost saving of switching to equivalent inhalers and its effect on health outcomes CI Bloom, I Douglas, J Olney, G D'Ancona, L Smeeth, JK Quint Thorax 74 (11), 1078-1086, 2019 | 30 | 2019 |
| Real-world effectiveness of anti–IL-5/5R therapy in severe atopic eosinophilic asthma with fungal sensitization J Dhariwal, AP Hearn, JE Kavanagh, G d’Ancona, L Green, M Fernandes, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (6), 2315-2320. e1, 2021 | 28 | 2021 |
| Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis BD Kent, G d'Ancona, M Fernandes, L Green, C Roxas, L Thomson, ... ERJ Open Research 6 (1), 2020 | 27 | 2020 |
| Adherence to wakefulness promoting medication in patients with narcolepsy L Pérez-Carbonell, E Lyons, V Gnoni, S Higgins, AI Otaiku, ... Sleep Medicine 70, 50-54, 2020 | 24 | 2020 |
| A pilot study to evaluate clinical competence in junior grade pharmacy practitioners GM Goldsmith, IP Bates, JG Davies, D McRobbie, DG Webb Pharmacy Education 3 (2), 2003 | 23 | 2003 |
| Prescribing patterns and treatment adherence in patients with asthma during the COVID-19 pandemic H Dhruve, G d’Ancona, S Holmes, J Dhariwal, AM Nanzer, DJ Jackson The Journal of Allergy and Clinical Immunology: In Practice 10 (1), 100-107. e2, 2022 | 21 | 2022 |
| Effectiveness and side‐effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practice C Thakrar, K Patel, G D'ancona, BD Kent, A Nesbitt, H Selsick, J Steier, ... Journal of sleep research 27 (4), e12627, 2018 | 20 | 2018 |
| Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma G d'Ancona, JE Kavanagh, J Dhariwal, AP Hearn, C Roxas, M Fernandes, ... Allergy 76 (7), 2238-2241, 2021 | 19 | 2021 |
| Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy AM Nanzer, A Chowdhury, A Raheem, C Roxas, M Fernandes, ... European Respiratory Journal 56 (1), 2020 | 14 | 2020 |
| Transitioning asthma care from adolescents to adults: severe asthma series AM Nanzer, A Lawton, G D’Ancona, A Gupta Chest 160 (4), 1192-1199, 2021 | 13 | 2021 |
| Improving adherence in chronic airways disease: are we doing it wrongly? G d'Ancona, J Weinman Breathe 17 (2), 2021 | 12 | 2021 |
| Effective quality improvement of thromboprophylaxis in acute medicine BM Clark, G d'Ancona, M Kinirons, BJ Hunt, A Hopper BMJ Quality & Safety 20 (5), 460-464, 2011 | 11 | 2011 |
David J. JacksonProfessor of Respiratory Medicine, Guy's & St Thomas' Hospitals, King's College LondonVerified email at gstt.nhs.uk
